معرفی
Paolo Magni is a Full Professor of Biomedical Engineering at the University of Pavia, Italy, where he serves as Director of the Bioinformatics, Mathematical Modelling and Synthetic Biology Lab. His primary appointment is in the Department of Industrial and Information Engineering within the Faculty of Engineering, and he maintains additional affiliation with the Center for Health Technologies (CHT). With a continuous academic career at the University of Pavia since 1999 spanning roles from Researcher to Full Professor, he has established significant leadership in computational biomedical engineering and translational research.
His academic qualifications include:
- Laurea cum laude in Electronics Engineering (Automatics), University of Pavia, 1993
- PhD in Bioengineering, University of Pavia, 1998
Professor Magni's research centers on quantitative modeling of dynamic biological systems, with expertise in Bayesian estimation, Markov chain Monte Carlo methods, and probabilistic data analysis techniques. His work spans pharmacometrics (PK/PD modeling), metabolic systems simulation, bioinformatics, and synthetic biology, consistently targeting solutions for complex clinical and biological challenges. He integrates machine learning and AI methodologies to advance intelligent data analysis in healthcare contexts.
His scholarly output exceeds 120 peer-reviewed journal publications and 400 conference proceedings, demonstrating sustained contributions to biomedical modeling. Publication trends reveal strong emphasis on pharmacometrics applications in oncology drug development, synthetic biology implementations, and Bayesian computational methods for physiological systems analysis.
Key recognitions include the Novartis Oncology Award (2017), multiple iGEM competition medals (2008-2011), and Pavia's Benemerenza di S. Siro award (2009). His spin-off companies Biomeris and enGenome received national excellence recognition.
As academic leader, he chairs both Bachelor and Master Bioengineering programs while serving as PhD program Vice-coordinator. His research portfolio features substantial funding including EU's DDMoRe project, MIUR grants across multiple categories (PRIN, FIRB, PNRR), and industry collaborations with Merck, Janssen, and Menarini focused on pharmacometrics and synthetic biology translation.
He directs the Bioinformatics, Mathematical Modelling and Synthetic Biology Lab and co-founded three spin-off entities: Biomeris (2012), enGenome (2016), and the DDMoRe Foundation (2016), driving innovation from academic research to healthcare applications.
